This authors request a revision to Figure 1 of this manuscript for numbers that are less than 11.
Please see below for the updated Figure 1.
In addition, the authors would like to add a disclaimer section to this article.
Disclaimer: The data reported here have been supplied by the United States Renal Data System (USRDS). The interpretation and reporting of these data are the responsibility of the author(s) and in no way should be seen as an official policy or interpretation of the U.S. government.
Finally, the authors request the addition of a final additional reference to this article.
U.S. Renal Data System. 2021 USRDS annual data report: Epidemiology of kidney disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, 2021.
Article info
Publication history
Published online: November 26, 2022
Identification
Copyright
© 2022 Elsevier Inc. All rights reserved.
ScienceDirect
Access this article on ScienceDirectLinked Article
- Increasing rates of parathyroidectomy to treat secondary hyperparathyroidism in dialysis patients with Medicare coverageSurgeryVol. 172Issue 1
- PreviewSecondary hyperparathyroidism affects nearly all patients with renal failure on dialysis. Medical treatment of secondary hyperparathyroidism has considerably evolved over the past 2 decades, with parathyroidectomy reserved for severe cases. The primary objective of our study was to understand how trends in medical treatments affected parathyroidectomy rates in patients with secondary hyperparathyroidism on dialysis.
- Full-Text
- Preview
00970-9&id=fx1.jpg){kind=link}